Sonendo, Inc. (SONX)

Market Cap	6.11M +336.3%
Revenue (ttm)	31.70M -8.5%
Net Income	-28.03M
EPS	-59.03
Shares Out	4.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	225
Open	1.280
Previous Close	1.000
Day's Range	1.280 - 1.280
52-Week Range	0.020 - 1.900
Beta	1.87
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 24, 2026

About Sonendo

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA tha...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 131
• Stock Exchange: OTCMKTS
• Ticker Symbol: SONX

Financial Performance

In 2024, Sonendo's revenue was $31.70 million, a decrease of -8.45% compared to the previous year's $34.63 million. Losses were -$28.03 million, -53.98% less than in 2023.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 22, 2026

Data Sources Report a data error